Together we will beat cancer

Donate

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

Read More

Meet our scientists investigating cancers’ weak spots, showing research ROCKs, and much more

We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.

Read More

‘A handful’ of gene faults can turn a healthy cell cancerous

Fewer than 10 errors in the DNA inside cells are enough to drive development of a cancer, according to new estimates.

Read More

News digest – obesity costs, radiologist shortage, breast cancer risk, and… avatars?

The growing global cost of obesity was in the news this week, along with genetic tests for breast cancer and a rare childhood cancer.

Read More

Study reveals genetic diversity of cancer that has spread

New research into the genetic and molecular features of cancers that have spread has revealed the diversity of these tumours and the immune cells within.

Read More

Cancer gene map uncovers potential new treatment targets

Researchers in the US have created comprehensive maps of genes that tumour cells rely on to survive.

Read More

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

Read More

Science Surgery: ‘What factors lead to a cell becoming cancerous?’

This entry is part 2 of 23 in the series Science Surgery

Our Science Surgery series answers your cancer science questions. Read our answer to Patrick’s question.

Read More

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

Read More

CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.

Read More